3d Medicines (sichuan) Co., Ltd.

This study is testing whether a new immunotherapy drug (envafolimab), given alone or together with a targeted cancer drug (lenvatinib), can help control advanced endometrial cancer. It is for people whose cancer has continued to grow or returned after standard chemotherapy. The m…

This study is testing whether combining two drugs—envafolimab (an immunotherapy) and lenvatinib (a targeted therapy)—is safe and effective for people with advanced solid tumors that have stopped responding to standard treatments. The trial will enroll about 170 adults with cancer…

This study is testing an experimental immunotherapy drug called KN035 for people with advanced solid tumors that have specific genetic markers (dMMR or MSI-H). The trial is for patients whose cancer has continued to grow despite receiving standard treatments. Researchers want to …

This study is testing whether an immunotherapy drug called ENVAFOLIMAB can help control advanced solid tumors that have stopped responding to standard treatments. About 126 patients with various advanced cancers will receive the drug as a simple injection under the skin every fou…

This study is for people with stage III non-small cell lung cancer that can be removed with surgery. It tests if adding a drug called envafolimab to standard chemotherapy, given both before and after surgery, works better and is safe compared to chemotherapy alone. The goal is to…